NCT03054506View on ClinicalTrials.gov

The Effect of CSP01 on Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

March 7, 2017

Primary Completion Date

May 10, 2018

Study Completion Date

February 1, 2019

Conditions
ConstipationChronic Idiopathic ConstipationIrritable Bowel Syndrome With Constipation
Interventions
DEVICE

CSP01

Subjects will take three capsules in the morning before breakfast, and three capsules at night before dinner each day for three weeks.

DEVICE

Carboxymethylcellulose (CMC)

Subjects will take three capsules in the morning before breakfast, and three capsules at night before dinner each day for three weeks.

DEVICE

Placebo

Subjects will take three capsules in the morning before breakfast, and three capsules at night before dinner each day for three weeks.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

Gelesis, Inc.
All Listed Sponsors
collaborator

Gelesis, Inc.

INDUSTRY

lead

Massachusetts General Hospital

OTHER

NCT03054506 - The Effect of CSP01 on Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation | Biotech Hunter | Biotech Hunter